Services and products for clinical and preclinical research
Stem cell and drug discovery scientists around the world use our solutions to translate their research into therapies.
Service Areas
On our blog
Mapping the Competitive Landscape of Human Tissue-Based Drug Discovery
Explore how REPROCELL leads in human tissue-based drug discovery, addressing market gaps and offering innovative, disease-relevant solutions for better therapeutic outcomes.
02 April 2026
5 Hard Truths About Bringing Stem Cell Therapies to the Clinic
Discover the essential truths behind developing clinical-grade stem cell therapies and learn how to navigate the complexities of GMP manufacturing successfully.
30 March 2026
Donor Variability in Ex Vivo Human Tissue Studies: Challenge, Feature, or Translational Advantage
Explore how donor variability in ex vivo human tissue studies enhances translational research by providing insights into patient heterogeneity and improving drug discovery.
12 March 2026
REPROCELL Attends Japan-Maryland Night 2026
REPROCELL was honored to attend Japan-Maryland Night on Wednesday March 4th 2026 Maryland State, USA, hosted by the Embassy of Japan (in Washington DC).
06 March 2026
Upcoming Events
Conferences we will be attending, and webinars hosted by us
Corporate News
REPROCELL Launches GMP Master Cell Bank Manufacturing for Clinical iPSCs
03 March 2026
REPROCELL Expands Product Portfolio with Addition of BioThrust™ ComfyCell Incu Bioreactor Platform
02 March 2026
28 January 2026
Investor Relations News
- Apr 02, 2026
-
Notice Regarding the Commencement of Manufacturing and Sales of Neoantigen-Derived Peptides
Mar 23, 2026 - Mar 11, 2026









